Letter to the Editor
Copyright ©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Stem Cells. Sep 26, 2024; 16(9): 842-845
Published online Sep 26, 2024. doi: 10.4252/wjsc.v16.i9.842
Mechanism of mesenchymal stem cells in liver regeneration: Insights and future directions
Yu-Xin Jin, Hang-Qi Hu, Jia-Cheng Zhang, Xi-Yan Xin, Yu-Tian Zhu, Yang Ye, Dong Li
Yu-Xin Jin, Hang-Qi Hu, Jia-Cheng Zhang, Xi-Yan Xin, Yu-Tian Zhu, Yang Ye, Dong Li, Department of Traditional Chinese Medicine, Peking University Third Hospital, Beijing 100191, China
Co-corresponding authors: Yang Ye and Dong Li.
Author contributions: Jin YX wrote the first draft of the manuscript; Hu HQ, Zhang JC, Xin XY, and Zhu YT contributed to review and editing; Ye Y and Li D conceived, reviewed, and revised this paper. Ye Y and Li D contributed equally and share the corresponding authorship.
Supported by Special Fund of the Beijing Clinical Key Specialty Construction Program, No. BJZKBC0011; and Clinical Key Project of Peking University Third Hospital, No. BYSYZD2023049.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Yang Ye, PhD, Research Assistant, Department of Traditional Chinese Medicine, Peking University Third Hospital, No. 49 North Garden Road, Haidian District, Beijing 100191, China. yeyang89@bjmu.edu.cn
Received: July 13, 2024
Revised: August 8, 2024
Accepted: August 26, 2024
Published online: September 26, 2024
Processing time: 72 Days and 23.4 Hours
Core Tip

Core Tip: This editorial discusses a recent article published in the World Journal of Stem Cells, which presents mesenchymal stem cells as a promising therapeutic approach for non-alcoholic fatty liver disease/non-alcoholic steatohepatitis. The study emphasizes targeting key molecular pathways such as glycolipid metabolism, inflammation, oxidative stress, endoplasmic reticulum stress, and fibrosis. We provide insights into their findings and explore relevant topics in this field.